chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angiogram cerebral normal, Arteriogram carotid normal, Blood immunoglobulin G normal, C-reactive protein normal, CSF protein increased
Clinical narrative: Transverse myelitis; bowel and urine issues; bowel and urine issues; she can't walk; numbness from her toes up to her breast on the left side and numbness from her toes to her groin on the right side; This is a spontaneous report from a contactable consumer (patient).  A 75-year-old female consumer received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 23Jan2021 at 13:00 at single dose into right arm for COVID-19 immunisation at the age of 75-year-old. Lot number was EL8982. Medical history was unknown and concomitant medications included blood pressure pills and cholesterol pills and vitamins. On 24Jan2021, the patient experienced transverse myelitis; the patient was hospitalized due to the event (hospitalization dates from 24Jan2021 to 7Feb2021; emergency room since 24Jan20211 noon). Consumer stated that when she was in the hospital, she was on heavy doses of steroids intravenous (IV) for 5 days. Blood work at the hospital was normal. Consumer left the hospital to go to the rehab facility on 30Jan2021, and then consumer left the rehab facility on 07Feb2021. Consumer stated that she could not walk. Consumer had complete numbness from her toes up to her breast on the left side and numbness from her toes to her groin on the right side. Consumer stated that she was still having issues with dragging her left leg, and with rehab, she was finally getting back some feeling, the numbness was still there but she was having bowel and urine issues. Consumer stated that her issues have somewhat improved with the help of rehab. The patient was recovering from the events.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram head normal, Culture urine positive, Escherichia urinary tract infection, Full blood count normal, Hyperreflexia
Clinical narrative: Transverse myelitis; bowel and urine issues; bowel and urine issues; she can't walk; numbness from her toes up to her breast on the left side and numbness from her toes to her groin on the right side; This is a spontaneous report from a contactable consumer (patient).  A 75-year-old female consumer received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 23Jan2021 at 13:00 at single dose into right arm for COVID-19 immunisation at the age of 75-year-old. Lot number was EL8982. Medical history was unknown and concomitant medications included blood pressure pills and cholesterol pills and vitamins. On 24Jan2021, the patient experienced transverse myelitis; the patient was hospitalized due to the event (hospitalization dates from 24Jan2021 to 7Feb2021; emergency room since 24Jan20211 noon). Consumer stated that when she was in the hospital, she was on heavy doses of steroids intravenous (IV) for 5 days. Blood work at the hospital was normal. Consumer left the hospital to go to the rehab facility on 30Jan2021, and then consumer left the rehab facility on 07Feb2021. Consumer stated that she could not walk. Consumer had complete numbness from her toes up to her breast on the left side and numbness from her toes to her groin on the right side. Consumer stated that she was still having issues with dragging her left leg, and with rehab, she was finally getting back some feeling, the numbness was still there but she was having bowel and urine issues. Consumer stated that her issues have somewhat improved with the help of rehab. The patient was recovering from the events.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Lumbar puncture abnormal, Magnetic resonance imaging brain normal, Magnetic resonance imaging spinal abnormal, Metabolic function test
Clinical narrative: Transverse myelitis; bowel and urine issues; bowel and urine issues; she can't walk; numbness from her toes up to her breast on the left side and numbness from her toes to her groin on the right side; This is a spontaneous report from a contactable consumer (patient).  A 75-year-old female consumer received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 23Jan2021 at 13:00 at single dose into right arm for COVID-19 immunisation at the age of 75-year-old. Lot number was EL8982. Medical history was unknown and concomitant medications included blood pressure pills and cholesterol pills and vitamins. On 24Jan2021, the patient experienced transverse myelitis; the patient was hospitalized due to the event (hospitalization dates from 24Jan2021 to 7Feb2021; emergency room since 24Jan20211 noon). Consumer stated that when she was in the hospital, she was on heavy doses of steroids intravenous (IV) for 5 days. Blood work at the hospital was normal. Consumer left the hospital to go to the rehab facility on 30Jan2021, and then consumer left the rehab facility on 07Feb2021. Consumer stated that she could not walk. Consumer had complete numbness from her toes up to her breast on the left side and numbness from her toes to her groin on the right side. Consumer stated that she was still having issues with dragging her left leg, and with rehab, she was finally getting back some feeling, the numbness was still there but she was having bowel and urine issues. Consumer stated that her issues have somewhat improved with the help of rehab. The patient was recovering from the events.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Metabolic function test normal, Muscular weakness, Myelitis, NIH stroke scale abnormal, Paraesthesia
Clinical narrative: Transverse myelitis; bowel and urine issues; bowel and urine issues; she can't walk; numbness from her toes up to her breast on the left side and numbness from her toes to her groin on the right side; This is a spontaneous report from a contactable consumer (patient).  A 75-year-old female consumer received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 23Jan2021 at 13:00 at single dose into right arm for COVID-19 immunisation at the age of 75-year-old. Lot number was EL8982. Medical history was unknown and concomitant medications included blood pressure pills and cholesterol pills and vitamins. On 24Jan2021, the patient experienced transverse myelitis; the patient was hospitalized due to the event (hospitalization dates from 24Jan2021 to 7Feb2021; emergency room since 24Jan20211 noon). Consumer stated that when she was in the hospital, she was on heavy doses of steroids intravenous (IV) for 5 days. Blood work at the hospital was normal. Consumer left the hospital to go to the rehab facility on 30Jan2021, and then consumer left the rehab facility on 07Feb2021. Consumer stated that she could not walk. Consumer had complete numbness from her toes up to her breast on the left side and numbness from her toes to her groin on the right side. Consumer stated that she was still having issues with dragging her left leg, and with rehab, she was finally getting back some feeling, the numbness was still there but she was having bowel and urine issues. Consumer stated that her issues have somewhat improved with the help of rehab. The patient was recovering from the events.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Protein total increased, Red blood cell sedimentation rate normal, Sensory level abnormal, Sensory loss, Urinary tract infection
Clinical narrative: Transverse myelitis; bowel and urine issues; bowel and urine issues; she can't walk; numbness from her toes up to her breast on the left side and numbness from her toes to her groin on the right side; This is a spontaneous report from a contactable consumer (patient).  A 75-year-old female consumer received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 23Jan2021 at 13:00 at single dose into right arm for COVID-19 immunisation at the age of 75-year-old. Lot number was EL8982. Medical history was unknown and concomitant medications included blood pressure pills and cholesterol pills and vitamins. On 24Jan2021, the patient experienced transverse myelitis; the patient was hospitalized due to the event (hospitalization dates from 24Jan2021 to 7Feb2021; emergency room since 24Jan20211 noon). Consumer stated that when she was in the hospital, she was on heavy doses of steroids intravenous (IV) for 5 days. Blood work at the hospital was normal. Consumer left the hospital to go to the rehab facility on 30Jan2021, and then consumer left the rehab facility on 07Feb2021. Consumer stated that she could not walk. Consumer had complete numbness from her toes up to her breast on the left side and numbness from her toes to her groin on the right side. Consumer stated that she was still having issues with dragging her left leg, and with rehab, she was finally getting back some feeling, the numbness was still there but she was having bowel and urine issues. Consumer stated that her issues have somewhat improved with the help of rehab. The patient was recovering from the events.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urine analysis abnormal, Visual impairment
Clinical narrative: Transverse myelitis; bowel and urine issues; bowel and urine issues; she can't walk; numbness from her toes up to her breast on the left side and numbness from her toes to her groin on the right side; This is a spontaneous report from a contactable consumer (patient).  A 75-year-old female consumer received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 23Jan2021 at 13:00 at single dose into right arm for COVID-19 immunisation at the age of 75-year-old. Lot number was EL8982. Medical history was unknown and concomitant medications included blood pressure pills and cholesterol pills and vitamins. On 24Jan2021, the patient experienced transverse myelitis; the patient was hospitalized due to the event (hospitalization dates from 24Jan2021 to 7Feb2021; emergency room since 24Jan20211 noon). Consumer stated that when she was in the hospital, she was on heavy doses of steroids intravenous (IV) for 5 days. Blood work at the hospital was normal. Consumer left the hospital to go to the rehab facility on 30Jan2021, and then consumer left the rehab facility on 07Feb2021. Consumer stated that she could not walk. Consumer had complete numbness from her toes up to her breast on the left side and numbness from her toes to her groin on the right side. Consumer stated that she was still having issues with dragging her left leg, and with rehab, she was finally getting back some feeling, the numbness was still there but she was having bowel and urine issues. Consumer stated that her issues have somewhat improved with the help of rehab. The patient was recovering from the events.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, Blood test, Gait disturbance, Hypoaesthesia, Myelitis transverse
Clinical narrative: Transverse myelitis; bowel and urine issues; bowel and urine issues; she can't walk; numbness from her toes up to her breast on the left side and numbness from her toes to her groin on the right side; This is a spontaneous report from a contactable consumer (patient).  A 75-year-old female consumer received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 23Jan2021 at 13:00 at single dose into right arm for COVID-19 immunisation at the age of 75-year-old. Lot number was EL8982. Medical history was unknown and concomitant medications included blood pressure pills and cholesterol pills and vitamins. On 24Jan2021, the patient experienced transverse myelitis; the patient was hospitalized due to the event (hospitalization dates from 24Jan2021 to 7Feb2021; emergency room since 24Jan20211 noon). Consumer stated that when she was in the hospital, she was on heavy doses of steroids intravenous (IV) for 5 days. Blood work at the hospital was normal. Consumer left the hospital to go to the rehab facility on 30Jan2021, and then consumer left the rehab facility on 07Feb2021. Consumer stated that she could not walk. Consumer had complete numbness from her toes up to her breast on the left side and numbness from her toes to her groin on the right side. Consumer stated that she was still having issues with dragging her left leg, and with rehab, she was finally getting back some feeling, the numbness was still there but she was having bowel and urine issues. Consumer stated that her issues have somewhat improved with the help of rehab. The patient was recovering from the events.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urinary incontinence
Clinical narrative: Transverse myelitis; bowel and urine issues; bowel and urine issues; she can't walk; numbness from her toes up to her breast on the left side and numbness from her toes to her groin on the right side; This is a spontaneous report from a contactable consumer (patient).  A 75-year-old female consumer received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 23Jan2021 at 13:00 at single dose into right arm for COVID-19 immunisation at the age of 75-year-old. Lot number was EL8982. Medical history was unknown and concomitant medications included blood pressure pills and cholesterol pills and vitamins. On 24Jan2021, the patient experienced transverse myelitis; the patient was hospitalized due to the event (hospitalization dates from 24Jan2021 to 7Feb2021; emergency room since 24Jan20211 noon). Consumer stated that when she was in the hospital, she was on heavy doses of steroids intravenous (IV) for 5 days. Blood work at the hospital was normal. Consumer left the hospital to go to the rehab facility on 30Jan2021, and then consumer left the rehab facility on 07Feb2021. Consumer stated that she could not walk. Consumer had complete numbness from her toes up to her breast on the left side and numbness from her toes to her groin on the right side. Consumer stated that she was still having issues with dragging her left leg, and with rehab, she was finally getting back some feeling, the numbness was still there but she was having bowel and urine issues. Consumer stated that her issues have somewhat improved with the help of rehab. The patient was recovering from the events.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal pain, Dizziness, Eye swelling, Fatigue, Feeling abnormal
Clinical narrative: Exhausted; Pain in left lung; left arm tingly; fingers icy; Neck pain; Groggy; face/eyes swollen; Did not feel well; Not thinking straight; Congestion; Muscle aches throughout; Sore throat; Chills; Trouble breathing; Dizziness; Headaches; Worse abdominal pains/abdominal (sharp) pains; Moderate pain at site; My head/mind felt "off"; My head/mind felt "off"; patient was out of sync like one side of brain was slower; affected balance; Face/eyes swollen/strange and unpleasant face swelling; This is a spontaneous report from a contactable consumer (patient). A 56-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EM9809 and expiry date unknown), via an unspecified route of administration on the left arm on 11Feb2021 at a single dose for COVID-19 immunization. Medical history included umbilical hernia, gallbladder adenocarcinoma, liver disease diagnosed in 2008 (in 2017, patient had an exam and was fully functional), ulcer, and allergies: plasma transfusion - severe hives. The patient's concomitant medications were not reported. Patient is not pregnant at time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. Patient has not been tested for COVID-19 since the vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received the first dose of BNT162B2 (product: COVID 19, brand: Pfizer, lot number: EL8982, vaccine location: left arm) on 21Jan2021. Approximately two hours after vaccination on 11Feb2021, patient experienced moderate pain at site and her head/mind felt off, patient was out of sync like one side of brain was slower; "affected balance". Patient had a strange and unpleasant face swelling. On 12Feb2021, patient experienced groggy, face/eyes swollen, did not feel well, and was not thinking straight. Patient had congestion, muscle aches throughout, sore throat, chills, trouble breathing, dizziness, headache, and abdominal (sharp) pains. On 15Feb2021, the patient was exhausted, had the worse abdominal pains, headaches, pain in left lung, left arm tingly, fingers icy, and neck pain. Adverse events resulted in: disability or permanent damage. Patient recovered with lasting effects. No treatment was received.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Feeling cold, Injection site pain, Malaise, Musculoskeletal stiffness, Myalgia
Clinical narrative: Exhausted; Pain in left lung; left arm tingly; fingers icy; Neck pain; Groggy; face/eyes swollen; Did not feel well; Not thinking straight; Congestion; Muscle aches throughout; Sore throat; Chills; Trouble breathing; Dizziness; Headaches; Worse abdominal pains/abdominal (sharp) pains; Moderate pain at site; My head/mind felt "off"; My head/mind felt "off"; patient was out of sync like one side of brain was slower; affected balance; Face/eyes swollen/strange and unpleasant face swelling; This is a spontaneous report from a contactable consumer (patient). A 56-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EM9809 and expiry date unknown), via an unspecified route of administration on the left arm on 11Feb2021 at a single dose for COVID-19 immunization. Medical history included umbilical hernia, gallbladder adenocarcinoma, liver disease diagnosed in 2008 (in 2017, patient had an exam and was fully functional), ulcer, and allergies: plasma transfusion - severe hives. The patient's concomitant medications were not reported. Patient is not pregnant at time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. Patient has not been tested for COVID-19 since the vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received the first dose of BNT162B2 (product: COVID 19, brand: Pfizer, lot number: EL8982, vaccine location: left arm) on 21Jan2021. Approximately two hours after vaccination on 11Feb2021, patient experienced moderate pain at site and her head/mind felt off, patient was out of sync like one side of brain was slower; "affected balance". Patient had a strange and unpleasant face swelling. On 12Feb2021, patient experienced groggy, face/eyes swollen, did not feel well, and was not thinking straight. Patient had congestion, muscle aches throughout, sore throat, chills, trouble breathing, dizziness, headache, and abdominal (sharp) pains. On 15Feb2021, the patient was exhausted, had the worse abdominal pains, headaches, pain in left lung, left arm tingly, fingers icy, and neck pain. Adverse events resulted in: disability or permanent damage. Patient recovered with lasting effects. No treatment was received.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Oropharyngeal pain, Paraesthesia, Pulmonary pain, Somnolence, Swelling face
Clinical narrative: Exhausted; Pain in left lung; left arm tingly; fingers icy; Neck pain; Groggy; face/eyes swollen; Did not feel well; Not thinking straight; Congestion; Muscle aches throughout; Sore throat; Chills; Trouble breathing; Dizziness; Headaches; Worse abdominal pains/abdominal (sharp) pains; Moderate pain at site; My head/mind felt "off"; My head/mind felt "off"; patient was out of sync like one side of brain was slower; affected balance; Face/eyes swollen/strange and unpleasant face swelling; This is a spontaneous report from a contactable consumer (patient). A 56-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EM9809 and expiry date unknown), via an unspecified route of administration on the left arm on 11Feb2021 at a single dose for COVID-19 immunization. Medical history included umbilical hernia, gallbladder adenocarcinoma, liver disease diagnosed in 2008 (in 2017, patient had an exam and was fully functional), ulcer, and allergies: plasma transfusion - severe hives. The patient's concomitant medications were not reported. Patient is not pregnant at time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. Patient has not been tested for COVID-19 since the vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received the first dose of BNT162B2 (product: COVID 19, brand: Pfizer, lot number: EL8982, vaccine location: left arm) on 21Jan2021. Approximately two hours after vaccination on 11Feb2021, patient experienced moderate pain at site and her head/mind felt off, patient was out of sync like one side of brain was slower; "affected balance". Patient had a strange and unpleasant face swelling. On 12Feb2021, patient experienced groggy, face/eyes swollen, did not feel well, and was not thinking straight. Patient had congestion, muscle aches throughout, sore throat, chills, trouble breathing, dizziness, headache, and abdominal (sharp) pains. On 15Feb2021, the patient was exhausted, had the worse abdominal pains, headaches, pain in left lung, left arm tingly, fingers icy, and neck pain. Adverse events resulted in: disability or permanent damage. Patient recovered with lasting effects. No treatment was received.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal pain, Balance disorder, Bradyphrenia, Chills, Cognitive disorder
Clinical narrative: Exhausted; Pain in left lung; left arm tingly; fingers icy; Neck pain; Groggy; face/eyes swollen; Did not feel well; Not thinking straight; Congestion; Muscle aches throughout; Sore throat; Chills; Trouble breathing; Dizziness; Headaches; Worse abdominal pains/abdominal (sharp) pains; Moderate pain at site; My head/mind felt "off"; My head/mind felt "off"; patient was out of sync like one side of brain was slower; affected balance; Face/eyes swollen/strange and unpleasant face swelling; This is a spontaneous report from a contactable consumer (patient). A 56-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EM9809 and expiry date unknown), via an unspecified route of administration on the left arm on 11Feb2021 at a single dose for COVID-19 immunization. Medical history included umbilical hernia, gallbladder adenocarcinoma, liver disease diagnosed in 2008 (in 2017, patient had an exam and was fully functional), ulcer, and allergies: plasma transfusion - severe hives. The patient's concomitant medications were not reported. Patient is not pregnant at time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. Patient has not been tested for COVID-19 since the vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received the first dose of BNT162B2 (product: COVID 19, brand: Pfizer, lot number: EL8982, vaccine location: left arm) on 21Jan2021. Approximately two hours after vaccination on 11Feb2021, patient experienced moderate pain at site and her head/mind felt off, patient was out of sync like one side of brain was slower; "affected balance". Patient had a strange and unpleasant face swelling. On 12Feb2021, patient experienced groggy, face/eyes swollen, did not feel well, and was not thinking straight. Patient had congestion, muscle aches throughout, sore throat, chills, trouble breathing, dizziness, headache, and abdominal (sharp) pains. On 15Feb2021, the patient was exhausted, had the worse abdominal pains, headaches, pain in left lung, left arm tingly, fingers icy, and neck pain. Adverse events resulted in: disability or permanent damage. Patient recovered with lasting effects. No treatment was received.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness, Dyspnoea, Eye swelling, Fatigue, Head discomfort
Clinical narrative: Exhausted; Pain in left lung; left arm tingly; fingers icy; Neck pain; Groggy; face/eyes swollen; Did not feel well; Not thinking straight; Congestion; Muscle aches throughout; Sore throat; Chills; Trouble breathing; Dizziness; Headaches; Worse abdominal pains/abdominal (sharp) pains; Moderate pain at site; My head/mind felt "off"; My head/mind felt "off"; patient was out of sync like one side of brain was slower; affected balance; Face/eyes swollen/strange and unpleasant face swelling; This is a spontaneous report from a contactable consumer (patient). A 56-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EM9809 and expiry date unknown), via an unspecified route of administration on the left arm on 11Feb2021 at a single dose for COVID-19 immunization. Medical history included umbilical hernia, gallbladder adenocarcinoma, liver disease diagnosed in 2008 (in 2017, patient had an exam and was fully functional), ulcer, and allergies: plasma transfusion - severe hives. The patient's concomitant medications were not reported. Patient is not pregnant at time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. Patient has not been tested for COVID-19 since the vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received the first dose of BNT162B2 (product: COVID 19, brand: Pfizer, lot number: EL8982, vaccine location: left arm) on 21Jan2021. Approximately two hours after vaccination on 11Feb2021, patient experienced moderate pain at site and her head/mind felt off, patient was out of sync like one side of brain was slower; "affected balance". Patient had a strange and unpleasant face swelling. On 12Feb2021, patient experienced groggy, face/eyes swollen, did not feel well, and was not thinking straight. Patient had congestion, muscle aches throughout, sore throat, chills, trouble breathing, dizziness, headache, and abdominal (sharp) pains. On 15Feb2021, the patient was exhausted, had the worse abdominal pains, headaches, pain in left lung, left arm tingly, fingers icy, and neck pain. Adverse events resulted in: disability or permanent damage. Patient recovered with lasting effects. No treatment was received.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Headache, Malaise, Mental disorder, Myalgia, Nasal congestion
Clinical narrative: Exhausted; Pain in left lung; left arm tingly; fingers icy; Neck pain; Groggy; face/eyes swollen; Did not feel well; Not thinking straight; Congestion; Muscle aches throughout; Sore throat; Chills; Trouble breathing; Dizziness; Headaches; Worse abdominal pains/abdominal (sharp) pains; Moderate pain at site; My head/mind felt "off"; My head/mind felt "off"; patient was out of sync like one side of brain was slower; affected balance; Face/eyes swollen/strange and unpleasant face swelling; This is a spontaneous report from a contactable consumer (patient). A 56-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EM9809 and expiry date unknown), via an unspecified route of administration on the left arm on 11Feb2021 at a single dose for COVID-19 immunization. Medical history included umbilical hernia, gallbladder adenocarcinoma, liver disease diagnosed in 2008 (in 2017, patient had an exam and was fully functional), ulcer, and allergies: plasma transfusion - severe hives. The patient's concomitant medications were not reported. Patient is not pregnant at time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. Patient has not been tested for COVID-19 since the vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received the first dose of BNT162B2 (product: COVID 19, brand: Pfizer, lot number: EL8982, vaccine location: left arm) on 21Jan2021. Approximately two hours after vaccination on 11Feb2021, patient experienced moderate pain at site and her head/mind felt off, patient was out of sync like one side of brain was slower; "affected balance". Patient had a strange and unpleasant face swelling. On 12Feb2021, patient experienced groggy, face/eyes swollen, did not feel well, and was not thinking straight. Patient had congestion, muscle aches throughout, sore throat, chills, trouble breathing, dizziness, headache, and abdominal (sharp) pains. On 15Feb2021, the patient was exhausted, had the worse abdominal pains, headaches, pain in left lung, left arm tingly, fingers icy, and neck pain. Adverse events resulted in: disability or permanent damage. Patient recovered with lasting effects. No treatment was received.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Neck pain, Oropharyngeal pain, Paraesthesia, Peripheral coldness, Pulmonary pain
Clinical narrative: Exhausted; Pain in left lung; left arm tingly; fingers icy; Neck pain; Groggy; face/eyes swollen; Did not feel well; Not thinking straight; Congestion; Muscle aches throughout; Sore throat; Chills; Trouble breathing; Dizziness; Headaches; Worse abdominal pains/abdominal (sharp) pains; Moderate pain at site; My head/mind felt "off"; My head/mind felt "off"; patient was out of sync like one side of brain was slower; affected balance; Face/eyes swollen/strange and unpleasant face swelling; This is a spontaneous report from a contactable consumer (patient). A 56-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EM9809 and expiry date unknown), via an unspecified route of administration on the left arm on 11Feb2021 at a single dose for COVID-19 immunization. Medical history included umbilical hernia, gallbladder adenocarcinoma, liver disease diagnosed in 2008 (in 2017, patient had an exam and was fully functional), ulcer, and allergies: plasma transfusion - severe hives. The patient's concomitant medications were not reported. Patient is not pregnant at time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. Patient has not been tested for COVID-19 since the vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received the first dose of BNT162B2 (product: COVID 19, brand: Pfizer, lot number: EL8982, vaccine location: left arm) on 21Jan2021. Approximately two hours after vaccination on 11Feb2021, patient experienced moderate pain at site and her head/mind felt off, patient was out of sync like one side of brain was slower; "affected balance". Patient had a strange and unpleasant face swelling. On 12Feb2021, patient experienced groggy, face/eyes swollen, did not feel well, and was not thinking straight. Patient had congestion, muscle aches throughout, sore throat, chills, trouble breathing, dizziness, headache, and abdominal (sharp) pains. On 15Feb2021, the patient was exhausted, had the worse abdominal pains, headaches, pain in left lung, left arm tingly, fingers icy, and neck pain. Adverse events resulted in: disability or permanent damage. Patient recovered with lasting effects. No treatment was received.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Somnolence, Swelling face, Vaccination site pain
Clinical narrative: Exhausted; Pain in left lung; left arm tingly; fingers icy; Neck pain; Groggy; face/eyes swollen; Did not feel well; Not thinking straight; Congestion; Muscle aches throughout; Sore throat; Chills; Trouble breathing; Dizziness; Headaches; Worse abdominal pains/abdominal (sharp) pains; Moderate pain at site; My head/mind felt "off"; My head/mind felt "off"; patient was out of sync like one side of brain was slower; affected balance; Face/eyes swollen/strange and unpleasant face swelling; This is a spontaneous report from a contactable consumer (patient). A 56-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EM9809 and expiry date unknown), via an unspecified route of administration on the left arm on 11Feb2021 at a single dose for COVID-19 immunization. Medical history included umbilical hernia, gallbladder adenocarcinoma, liver disease diagnosed in 2008 (in 2017, patient had an exam and was fully functional), ulcer, and allergies: plasma transfusion - severe hives. The patient's concomitant medications were not reported. Patient is not pregnant at time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. Patient has not been tested for COVID-19 since the vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received the first dose of BNT162B2 (product: COVID 19, brand: Pfizer, lot number: EL8982, vaccine location: left arm) on 21Jan2021. Approximately two hours after vaccination on 11Feb2021, patient experienced moderate pain at site and her head/mind felt off, patient was out of sync like one side of brain was slower; "affected balance". Patient had a strange and unpleasant face swelling. On 12Feb2021, patient experienced groggy, face/eyes swollen, did not feel well, and was not thinking straight. Patient had congestion, muscle aches throughout, sore throat, chills, trouble breathing, dizziness, headache, and abdominal (sharp) pains. On 15Feb2021, the patient was exhausted, had the worse abdominal pains, headaches, pain in left lung, left arm tingly, fingers icy, and neck pain. Adverse events resulted in: disability or permanent damage. Patient recovered with lasting effects. No treatment was received.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Flushing, Pharyngeal swelling
Clinical narrative: Patient received vaccine at 1008. At 1038 patient presenting with c/o "throat tightness" and flushing of the skin. Pt has history of anaphylaxis with shellfish, contrast, and allergy shots.  Ems notified in house. 1047: VSS: B/P 130/77, HR 77, SaO2 95-97% on RA.  Appears in NAD, Skin pink, warm and dry.  Patient given water and able to swallow  without issues. Observed patient for 45 minutes and symptoms resolved patient cleared by EMS and discharged home.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Flushing, Throat tightness
Clinical narrative: Patient received vaccine at 1008. At 1038 patient presenting with c/o "throat tightness" and flushing of the skin. Pt has history of anaphylaxis with shellfish, contrast, and allergy shots.  Ems notified in house. 1047: VSS: B/P 130/77, HR 77, SaO2 95-97% on RA.  Appears in NAD, Skin pink, warm and dry.  Patient given water and able to swallow  without issues. Observed patient for 45 minutes and symptoms resolved patient cleared by EMS and discharged home.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood pressure measurement, Feeling hot, Flushing, Heart rate, Oxygen saturation
Clinical narrative: Patient received vaccine at 1008. At 1038 patient presenting with c/o "throat tightness" and flushing of the skin. Pt has history of anaphylaxis with shellfish, contrast, and allergy shots.  Ems notified in house. 1047: VSS: B/P 130/77, HR 77, SaO2 95-97% on RA.  Appears in NAD, Skin pink, warm and dry.  Patient given water and able to swallow  without issues. Observed patient for 45 minutes and symptoms resolved patient cleared by EMS and discharged home.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Skin discolouration, Throat tightness
Clinical narrative: Patient received vaccine at 1008. At 1038 patient presenting with c/o "throat tightness" and flushing of the skin. Pt has history of anaphylaxis with shellfish, contrast, and allergy shots.  Ems notified in house. 1047: VSS: B/P 130/77, HR 77, SaO2 95-97% on RA.  Appears in NAD, Skin pink, warm and dry.  Patient given water and able to swallow  without issues. Observed patient for 45 minutes and symptoms resolved patient cleared by EMS and discharged home.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Dyspnoea, Gait disturbance, Mobility decreased, Skin tightness
Clinical narrative: weakness in 1 hour sore arm had to use rescue inhaler  between 3 and 10 hours at 10 hours lympanedopthy and facial swelling on L side f face 11 hours after injection contaced MD
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swelling face
Clinical narrative: weakness in 1 hour sore arm had to use rescue inhaler  between 3 and 10 hours at 10 hours lympanedopthy and facial swelling on L side f face 11 hours after injection contaced MD
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Asthma, Lymphadenopathy, Pain in extremity, Swelling face
Clinical narrative: weakness in 1 hour sore arm had to use rescue inhaler  between 3 and 10 hours at 10 hours lympanedopthy and facial swelling on L side f face 11 hours after injection contaced MD
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swelling, Swelling face
Clinical narrative: 12 hours after 1st covid vaccine she began having swelling of the left side of her face, cheek, eyelid. She also noticed tender lymph notes in her neck on the left side. Denied any recent illness, no rash/hives. Denies problems breathing, no swelling of tongue.  Seen on 2/25/21 at PCP office. Assessment by Dr. on 2/25: "mild residual soft tissue swelling noted in the cheek laterally and into the chin and skin above the left eye. There is tenderness to palpation along the left  side of her neck with mild fullness of the lymph nodes.
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Soft tissue swelling, Swelling face, Swelling of eyelid, Tenderness
Clinical narrative: 12 hours after 1st covid vaccine she began having swelling of the left side of her face, cheek, eyelid. She also noticed tender lymph notes in her neck on the left side. Denied any recent illness, no rash/hives. Denies problems breathing, no swelling of tongue.  Seen on 2/25/21 at PCP office. Assessment by Dr. on 2/25: "mild residual soft tissue swelling noted in the cheek laterally and into the chin and skin above the left eye. There is tenderness to palpation along the left  side of her neck with mild fullness of the lymph nodes.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cerebrovascular accident, Confusional state, Death, Unresponsive to stimuli
Clinical narrative: Stroke; This is a spontaneous report from a contactable nurse (patient wife). A 73-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK4176, expiry date unknown) via an unspecified route of administration on 23Jan2021 09:30 in arm at single dose to avoid COVID-19. Medical history included arteriovenous malformation (AVM) that had been treated over the past year and a half, radiotherapy from Sep2020 that he had it once, stroke from Jul2019, high blood pressure and elevated cholesterol. No other suspected Pfizer vaccine and no additional vaccines administered on same date. No other vaccine received prior vaccinations within 4 weeks and no event following prior vaccinations. Family medical history relevant to adverse event was reported as none. Concomitant medication included thiamine and had been on it for probably a year, amlodipine and had been on it for 10 years, vitamin D, donepezil and he had been on 5 mg and it was increased to 10 mg daily. It was increased less than a year ago, folic acid, atorvastatin calcium and had been on it maybe 5 months for elevated cholesterol and Multivitamin daily and he had been on it for quite a while. The patient experienced stroke between 12:00 PM and 4:00 PM on 25Jan2021, two days after receiving the COVID19 vaccine. The patient was hospitalized for stroke from 25Jan2021 to 27Jan2021. The patient died due to stroke on 27Jan2021. The outcome of the event was fatal. An autopsy was not performed. No investigation assessment.; Sender's Comments: Based on temporal association, a causal association between the reported event stroke and BNT162B2 cannot be completely excluded. Note however that patient has history of AVM, previous stroke and high blood pressure that may have contributed to the event fatal stroke. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.; Reported Cause(s) of Death: Stroke
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cerebrovascular accident
Clinical narrative: Stroke; This is a spontaneous report from a contactable nurse (patient wife). A 73-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK4176, expiry date unknown) via an unspecified route of administration on 23Jan2021 09:30 in arm at single dose to avoid COVID-19. Medical history included arteriovenous malformation (AVM) that had been treated over the past year and a half, radiotherapy from Sep2020 that he had it once, stroke from Jul2019, high blood pressure and elevated cholesterol. No other suspected Pfizer vaccine and no additional vaccines administered on same date. No other vaccine received prior vaccinations within 4 weeks and no event following prior vaccinations. Family medical history relevant to adverse event was reported as none. Concomitant medication included thiamine and had been on it for probably a year, amlodipine and had been on it for 10 years, vitamin D, donepezil and he had been on 5 mg and it was increased to 10 mg daily. It was increased less than a year ago, folic acid, atorvastatin calcium and had been on it maybe 5 months for elevated cholesterol and Multivitamin daily and he had been on it for quite a while. The patient experienced stroke between 12:00 PM and 4:00 PM on 25Jan2021, two days after receiving the COVID19 vaccine. The patient was hospitalized for stroke from 25Jan2021 to 27Jan2021. The patient died due to stroke on 27Jan2021. The outcome of the event was fatal. An autopsy was not performed. No investigation assessment.; Sender's Comments: Based on temporal association, a causal association between the reported event stroke and BNT162B2 cannot be completely excluded. Note however that patient has history of AVM, previous stroke and high blood pressure that may have contributed to the event fatal stroke. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.; Reported Cause(s) of Death: Stroke
Age: 89.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Computerised tomogram head normal, Contusion, Culture urine negative, Epistaxis, Full blood count
Clinical narrative: Patient presented for SECOND vaccination and cleared observation period without incident.  Some amount of time later the patient presented to a PCP with a wbc that dropped from ~215 to less than 3.
Age: 89.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Haemoglobin normal, Influenza virus test negative, Metabolic function test, Metabolic function test normal, Petechiae
Clinical narrative: Patient presented for SECOND vaccination and cleared observation period without incident.  Some amount of time later the patient presented to a PCP with a wbc that dropped from ~215 to less than 3.
Age: 89.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Platelet count decreased, Platelet transfusion, SARS-CoV-2 test negative, Urine analysis normal, White blood cell count normal
Clinical narrative: Patient presented for SECOND vaccination and cleared observation period without incident.  Some amount of time later the patient presented to a PCP with a wbc that dropped from ~215 to less than 3.
Age: 89.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: White blood cell count decreased
Clinical narrative: Patient presented for SECOND vaccination and cleared observation period without incident.  Some amount of time later the patient presented to a PCP with a wbc that dropped from ~215 to less than 3.
Age: 89.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood blister, Body temperature, Chills, Epistaxis, Illness
Clinical narrative: Patient presented for SECOND vaccination and cleared observation period without incident.  Some amount of time later the patient presented to a PCP with a wbc that dropped from ~215 to less than 3.
Age: 89.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain, Petechiae, Platelet count, Platelet count decreased, Pyrexia
Clinical narrative: Patient presented for SECOND vaccination and cleared observation period without incident.  Some amount of time later the patient presented to a PCP with a wbc that dropped from ~215 to less than 3.
Age: 89.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: Patient presented for SECOND vaccination and cleared observation period without incident.  Some amount of time later the patient presented to a PCP with a wbc that dropped from ~215 to less than 3.
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood ethanol normal, Chest X-ray normal, Chills, Computerised tomogram head normal, Differential white blood cell count normal
Clinical narrative: Patient got vaccine on 2/3/21. Developed fever  of 102 F and malaise on 2/4/21. Reported "low grade fever" on 2/5/21. Had witnessed convulsive seizure on 2/7/21 and went to the ED for evaluation.
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Electrocardiogram normal, Electroencephalogram normal, Feeling abnormal, Full blood count normal, Generalised tonic-clonic seizure
Clinical narrative: Patient got vaccine on 2/3/21. Developed fever  of 102 F and malaise on 2/4/21. Reported "low grade fever" on 2/5/21. Had witnessed convulsive seizure on 2/7/21 and went to the ED for evaluation.
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Magnetic resonance imaging brain normal, Metabolic function test normal, Pyrexia, Troponin I normal
Clinical narrative: Patient got vaccine on 2/3/21. Developed fever  of 102 F and malaise on 2/4/21. Reported "low grade fever" on 2/5/21. Had witnessed convulsive seizure on 2/7/21 and went to the ED for evaluation.
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Computerised tomogram head, Electrocardiogram abnormal, Feeling abnormal, Malaise, Pyrexia
Clinical narrative: Patient got vaccine on 2/3/21. Developed fever  of 102 F and malaise on 2/4/21. Reported "low grade fever" on 2/5/21. Had witnessed convulsive seizure on 2/7/21 and went to the ED for evaluation.
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Seizure, Sinus tachycardia
Clinical narrative: Patient got vaccine on 2/3/21. Developed fever  of 102 F and malaise on 2/4/21. Reported "low grade fever" on 2/5/21. Had witnessed convulsive seizure on 2/7/21 and went to the ED for evaluation.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Malaise, Muscular weakness, Vertigo
Clinical narrative: 2.17.21 Symptoms of generalized muscle weakness, speech abnormality, dizziness, fatigue, and visual disturbance started about 4pm.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Fatigue, Full blood count, Metabolic function test, Muscular weakness
Clinical narrative: 2.17.21 Symptoms of generalized muscle weakness, speech abnormality, dizziness, fatigue, and visual disturbance started about 4pm.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Red blood cell sedimentation rate, Speech disorder, Visual impairment
Clinical narrative: 2.17.21 Symptoms of generalized muscle weakness, speech abnormality, dizziness, fatigue, and visual disturbance started about 4pm.
Age: 92.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram normal, Death, Fall, Laboratory test, White blood cell count increased
Clinical narrative: Pt had his second covid vaccine and overnight he was found down, obtunded. Ultimately diagnosed with NSTEMI, acute HFrEF, cardiogenic shock, rhabdomyolysis, AKI
Age: 92.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: X-ray normal
Clinical narrative: Pt had his second covid vaccine and overnight he was found down, obtunded. Ultimately diagnosed with NSTEMI, acute HFrEF, cardiogenic shock, rhabdomyolysis, AKI